newsfilter
← Latest News
Business Wire·

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024

Paragon 28, Inc. (NYSE:FNA) ("Paragon 28" or "P28"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited net revenue for the